Directory
>
Adam Del Corral Pharmd
Adam Del Corral Pharmd
Vice President, Compound Development Team Leader, GU Cancers (bladder and prostate) | Johnson & Johnson Innovative Medicine
United States
Adam Del Corral Pharmd
Summary
Adam Del Corral is a seasoned clinical development leader with a PharmD and over 16 years of extensive experience in the pharmaceutical industry, particularly in oncology and malignant hematology. He currently serves as the Vice President and Compound Development Team Leader at Janssen Pharmaceutical Companies, where he leads teams in developing innovative therapies for genitourinary cancers. Adam has a proven track record of success in clinical trial design and execution, regulatory submissions, and cross-functional team leadership. His expertise spans various therapeutic areas, and he has been instrumental in bringing multiple oncology compounds to market. Adam's strategic vision and commitment to patient outcomes drive his leadership style, fostering a culture of scientific excellence and continuous improvement within his teams. He is passionate about advancing cancer treatments and is recognized for his contributions to the field.
Adam Del Corral Pharmd
Work Experience
Vice President, Compound Development Team Leader, GU Cancers (bladder and prostate) at
Johnson & Johnson Innovative Medicine
April 2024 - Present
Senior Director, Compound Development Team Leader, CARVYKTI at
Johnson & Johnson Innovative Medicine
July 2020 - April 2024
Senior Director, Global Project Leader, Hematology/ Oncology/ Cell Therapy at
Bristol Myers Squibb
November 2018 - July 2020
Senior Director, Hematology/Oncology Global CR&D Strategy at
Bristol Myers Squibb
August 2016 - November 2018
Senior Director, Lead Clinical Research Scientist, Oncology at
Bristol Myers Squibb
October 2015 - July 2016
Director, Lead Clinical Research Scientist, Oncology at
Bristol Myers Squibb
May 2013 - September 2015
Senior Clinical Research Scientist, Oncology at
Bristol Myers Squibb
May 2012 - April 2013
Clinical Trial Head, Oncology Global CR&D at
Novartis
June 2011 - May 2012
Expert Clinical Manager, Oncology Global CR&D at
Novartis
September 2008 - June 2011
Senior Clinical Manager, Oncology Global CR&D at
Novartis
June 2007 - August 2008
Adam Del Corral Pharmd
Education
Rutgers University–New Brunswick, Doctor Of Pharmacy (Pharmd)
January 2001 - January 2007
Frequently Asked Questions about Adam Del Corral Pharmd
What is Adam Del Corral Pharmd email address?
Adam Del Corral Pharmd's primary email address is **********@janssen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Adam Del Corral Pharmd work for?
Adam Del Corral Pharmd is a Vice President, Compound Development Team Leader, GU Cancers (bladder and prostate) at Johnson & Johnson Innovative Medicine.
Where Adam Del Corral Pharmd graduated from?
Adam Del Corral Pharmd holds a degree in from Rutgers University–New Brunswick.
How can I directly contact Adam Del Corral Pharmd?
To contact Adam Del Corral Pharmd directly, you can use the email address **********@janssen.com. Complete contact information is available upon registration with Muraena.
Who is Adam Del Corral Pharmd?
Adam Del Corral is a seasoned clinical development leader with a PharmD and over 16 years of extensive experience in the pharmaceutical industry, particularly in oncology and malignant hematology. He currently serves as the Vice President and Compound Development Team Leader at Janssen Pharmaceutical Companies, where he leads teams in developing innovative therapies for genitourinary cancers. Adam has a proven track record of success in clinical trial design and execution, regulatory submissions, and cross-functional team leadership. His expertise spans various therapeutic areas, and he has been instrumental in bringing multiple oncology compounds to market. Adam's strategic vision and commitment to patient outcomes drive his leadership style, fostering a culture of scientific excellence and continuous improvement within his teams. He is passionate about advancing cancer treatments and is recognized for his contributions to the field.
Adam`s contact details
**********@janssen.com
**********@its.jnj.com
Colleagues
New Jersey State Advisory Board Member
Company Group Chairman, Johnson & Johnson innovative Medicine, Asia Pacific
Senior Director, Research & Development, Cardiopulmonary
Senior Director, Global Commercial Strategy - Prostate